European Congress on

Vaccines & Vaccination

Theme: Drifts in Traditional and Innovative Vaccines Approaches

Event Date & Time

Event Location

Mercure Budapest Buda, Budapest, Hungary

18 years of lifescience communication


Performers / Professionals From Around The Globe

Conference Speaker

Satya Parida

The Pirbright Institute

Conference Speaker

Alexander Suvorov

Institute of Experimental Medicine

Conference Speaker

Emmanuel Drouet

University of Grenoble

Conference Speaker

Jeanne Moldenhauer

Excellent Pharma Consulting

Conference Speaker

Adel M. Talaat

University of Wisconsin-Madison

Conference Speaker

Ayoub A. Bazzaz

University of Kerkuk

Conference Speaker

Kathleen Hefferon

Cornell University

Conference Speaker

Leonardo Saenz

University of Chile

Conference Speaker

Mohamed Dilai

Hassan II Institute of Agronomy and Veterinary Medicine

Conference Speaker

Brian G. Hubka

Contamination Prevention Technologies

Conference Speaker


Rwanda Biomedical Center

Conference Speaker

George Kamkamidze

University of Georgia

Tracks & Key Topics

Euro Vaccines 2018

About Conference

Vaccines Committee delighted to welcome all the interested and enthusiastic participants across the globe to its prestigious ‘European Congress on Vaccines & Vaccination’ to be held during October 26-27, 2018 at Budapest, Hungary. Which highlights the theme “Drifts in Traditional and innovative Vaccines Approaches”. Euro Vaccines 2018 is a two-day conference concentrating on Interactive Sessions & Sub-sessions emphasized on innovation and new trends on vaccines, keynote lectures from Senior Scientists and industry experts, panel discussions, poster competitions, and Young Researcher Forum. The conference program will feature well-known and thought to provoke speakers to interactive discussion sessions, prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions  


Why attend??

The Vaccine & Vaccination conference interacts with members across the globe focused on learning about vaccines and its specialties. This is the single best opportunity to reach the largest participants. Sharing the knowledge and demonstrations, information and B2B meetings with industrialists and potential clients to make a splash with innovative products live and brand recognition at this event. World renowned speakers, the most recent techniques, and the latest updates on vaccines are hallmarks of this conference.

EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multi-professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.

Euroscicon are corporate members of the following Organizations

  • Royal Society of Biology
  • IBMS
  • British Society for Immunology
  • Rare Care UK
  • Opportunities for Conference Attendees
  • For Researchers & Faculty
  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering

Marketing and Networking with clients

Euroscicon organizes International Vaccine Meetings annually across Europe, Austria, Ireland, Germany, France, Liechtenstein, Lithuania, Finland, Luxembourg, Hungary, Italy, Norway, Poland, Denmark, Macedonia, Greece, Portugal, Romania, Czech Republic, Switzerland, United Kingdom, Belgium, Scotland, Latvia, Ukraine, Sweden, Denmark, Spain, Netherlands Russia, Bulgaria, France, with solitary subject of quickening logical revelations.



1. HIV/AIDS Vaccines

The long-term aim is to develop a nontoxic and effective vaccine that defends people worldwide after getting infected with HIV. However, even if a vaccine only defends some people who get vaccinated, or even if it affords less than total protection by reducing the threat of infection, it could still have a major impact on the rates of transmission and help control the pandemic, particularly for populations at high risk of HIV infection. A partially effective vaccine could decrease the number of people who get infected with HIV, further reducing the number of people who can pass the virus on to others. By considerably reducing the number of new-fangled infections, we can stop the widespread.

  • HIV Vaccine Strategies
  • T cell-based Vaccines
  • B cell-based Vaccines
  • Innate & Mucosal Immunity
  • Viral Vaccine Vectors

2. Veterinary Vaccines

The main objectives of veterinary immunizations are to advance the wellbeing and welfare of companion creatures, increment making of domesticated animals in a sparing way, and stay away from creature to-human transmission from together local creatures and untamed life. These diverse points have assimilated to assorted strategies to the advance of veterinary antibodies from unrefined in the past valid entire pathogen arrangements to molecularly unmistakable subunit immunizations, on a very basic level built animals previously figments, vectored antigen definitions, other than stark-bare DNA infusions. The last productive result of antibody examination and improvement is the age of an item that will be available in the commercial centre or that will be utilized as a part of the field to achieve wanted results. As itemized in this survey, fruitful veterinary antibodies have been delivered in inconsistency of viral, bacterial, protozoal, and multicellular pathogens, which in numerous behaviours have driven the field in the application and variety of novel advancements. These veterinary immunizations have devoured, and keep on having, a noteworthy effect on creature prosperity and generation as well as on human wellbeing through expanding innocuous nourishment supplies and anticipating creature to-human communicate of irresistible infections. The proceeded with connection amongst creatures and human analysts and wellbeing experts will be of real significance for acquainting new advancements, giving creature models of ailment, and undermining new and developing irresistible infections.

  • Efficacy of Veterinary Medicine
  • Animal Health Outcomes
  • Recent Advances in Animal Vaccination
  • Current Status of Veterinary Vaccines
  • Vaccines for Livestock Diseases

3. Managing and Storage of Vaccines

Inoculations help spare lives, forestall genuine ailments, and are perceived as a standout amongst the best general wellbeing mediations accessible today. Immunizations immunology programs are among the most financially savvy approaches to forestall illness. The accomplishment of these projects depends vigorously upon the high vaccination scope of the objective gathering and immunization stock administration, including appropriate capacity and treatment of antibodies. This archive is expected to help all social insurance suppliers with how to appropriately store and handle commonly supported immunizations. Preceding putting away antibody, medicinal services suppliers are required to comprehend and meet with the immunization stockpiling and dealing with prerequisites showed in this record.

  • Vaccine Administration
  • Timing and Spacing of Vaccine Doses
  • Training and Education for Proper Storage
  • Vaccine Inventory Management, Transport, and Preparation

4. Vaccine Safety and Efficacy

For the past two centuries, vaccines have provided a safe and effective means of preventing a number of infectious diseases. Although the safety of some vaccines has been questioned in recent years, the currently available vaccines are more than a millionfold safer than the diseases they are designed to prevent. Vaccines, however, should always be used in conjunction with other public health interventions. One important intervention is education because the general public can be led to believe that vaccines are unsafe and not needed by misinformation readily available electronically and in print. Not only are some vaccines available via injection but other vaccines are also given orally or intranasally. New vaccines are being studied for topical and intravaginal use. In addition, new systems are being developed for more efficient production of vaccines, especially for influenza. Vaccines are currently available for only a limited number of viral and bacterial diseases. In the future, it is anticipated that safe and effective vaccines will be developed against a number of other viral and bacterial infections as well as fungal and protozoan diseases.

  • Vaccines: A boon or curse
  • Adverse Drug Reaction
  • Vaccine Safety Programs
  • Development of Pandemic Vaccines
  • Current Issues
  • Vaccine Preventable Diseases
  • Vaccine Pharmacovigilance

5. Vaccine Research and Development

Antibody Research and Development includes immunization investigate in the field of irresistible maladies in the aggregate reconciliation, including growth, AIDS and allergies. New immunizations are always being looked into and created. There has been a relentless movement in the progression of immunizations that has prompted advancement of authorized vaccines. Combination antibodies have been presented which can keep a few illnesses immediately. Hazard profile of antibody against unending maladies is modestly high when contrasted with those against intense infections.

  • Vaccine Research in Europe
  • Therapeutic Vaccination for Auto Immune Diseases
  • Vaccine Management & Quality Assurance
  • Vaccine Clinical Trials
  • Vaccine Discovery, Development and Formulation

6. In Silica Based Vaccine Designing

Insilco base planning offers economical, particular, potential and simple methods for antibody improvement and a standard approach in this post-genomic period. Epitope based antibody outlining has turned into a promising methodology with propels in genomicsproteomics. Forecast of epitopes by means of in silico apparatuses in antibody planning procedure can essentially limit the time and cost required in the improvement procedure. Conventional strategies for antibody creation can be expanded by insilico approaches.

  • Reverse Vaccinology
  • Immunoinformatics Study
  • Conformation Analysis of Vaccines
  • Development of Tools and Software

7. Mucosal Vaccines

Mucosal tissues (e.g. nasal, oral, visual, rectal, vaginal) cover an extensive surface of the body. It is basic to create methodologies for killing the irresistible specialist at these surfaces since contaminations are started at these destinations. Mucosal inoculation includes the organization of immunizations at least one mucosal locales prompting enlistment of insusceptible reactions at that site, or other mucosal destinations. Vaccination includes the conveyance of antigens to the mucosal invulnerable framework. The antigen conveyance frameworks may involve a straightforward support arrangement with/without adjuvants or a propelled particulate detailing, for example, liposomes or nanoparticles. The most normally assessed course for mucosal antigen conveyance is oral, however different courses have additionally been investigated.

  • Edible Vaccines
  • Common Vaccination given by Mucosal Route
  • Mucosal Vaccines Delivery
  • Challenges in Mucosal Vaccine Delivery

8. Vaccines for Immune mediated diseases

Patients with insusceptible interceded fiery illnesses (IMID, for example, RA, IBD or psoriasis, are at expanded danger of contamination, in part due to the ailment itself, yet for the most part as a result of treatment with immunomodulatory or immunosuppressive medications. Regardless of their hoisted chance for immunization-preventable illness, inoculation scope in IMID patients is shockingly low. This audit condenses current writing information on immunization wellbeing and viability in IMID patients treated with immunosuppressive or immunomodulatory sedates and details beast-hone proposals on inoculation in this populace. Particularly in the present time of organic treatments, including TNF-blocking operators, extraordinary thought ought to be given to immunization techniques in IMID patients. Clinical confirmation demonstrates that inoculation of IMID patients does not increment clinical parameters of illness action. Live immunizations are contraindicated in immunocompromised people; however non-live antibodies can securely be given. In spite of the fact that the lessened nature of the safe reaction in patients under immunotherapy may negatively affect inoculation viability in this populace, satisfactory humoral reaction to immunization in IMID patients has been shown for hepatitis B, flu and pneumococcal immunization. Immunization status is best checked and refreshed before the beginning of immunomodulatory treatment: live antibodies are not contraindicated around then and inactivated antibodies inspire an ideal safe reaction in immunocompetent people.

  • Information on the Benefits and Risks of Immunization
  • Cost Ratio of Immunization
  • Vaccine Schedule and Administration
  • Integrity of the Immunization Program
  • Global Vaccination and Challenges
  • Global and Regional Immunization
  • Future Studies

9. Fish Vaccines

Inoculation assumes an imperative part in vast scale business angle cultivating. As a rule, exactly created immunizations in light of inactivated bacterial pathogens have turned out to be exceptionally effective in angle. Less industrially accessible viral antibodies and no parasite immunizations exist. Considerable viability information is accessible for new fish immunizations and propelled innovation has been executed. Fish antibodies can be conveyed a similar way we vaccinate warm-blooded creatures. Fish can be inoculated by drenching in antibody for a brief timeframe.

  • Oral Vaccination
  • Immersion Vaccination
  • Injection Vaccination
  • Vaccination Techniques

10. Production and Research of Vaccines

Creation and Research of Vaccines with the development and development of new infections, the need and interest for imaginative antibodies keep on developing. Be that as it may, antibody improvement is an intricate, relentless, and costly process. It includes a request of numerous advances, adequate assets for clinical trials and assembling offices, complex scale-up forms, information in exploring requesting administrative situations in different areas, and overseeing imperative wellbeing checking.

  • Concepts in Infectious Disease Research
  • Plants Used as Bioreactor
  • Preparation of the Vaccine Strain
  • Vaccine Database and Analysis System
  • Technique Used In Vaccine Production
  • Challenges Faced in Vaccine Discovery
  • Vaccine Bulk Manufacture

11. Combination and Conjugate Vaccines

Mix immunizations take at least two antibodies that could be given separately and place them into one shot. Youngsters get an indistinguishable security from they do from singular antibodies given independently—yet with less shots. The utilization of blend immunizations enhances opportune inoculation scope, as indicated by a few examinations. Conjugate polysaccharide immunizations are those in which the polysaccharide is synthetically connected to a protein. This linkage makes the polysaccharide a stronger antibody. Polysaccharide coatings mask a bacterium's antigens with the goal that the youthful insusceptible frameworks of babies and more youthful youngsters can't perceive or react to them. Conjugate antibodies, an exceptional kind of subunit immunization, get around this issue. When making a conjugate immunization, antigens or toxoids from an organism that a baby's resistant framework can perceive to the polysaccharides are connected. The linkage enables the youthful safe framework to respond to polysaccharide coatings and safeguard against the malady causing bacterium.

  •  Epidemiology and Methodology 
  •  Glycoconjugate Vaccines
  •  Hib Vaccines
  •  Vaccines Formulation and Technologies used in Conjugated Vaccines
  •  N. meningitidis Vaccines
  •  S. pneumoniae Vaccines

12. Vaccines & Immunization

An immune response is a natural arranging that gives dynamic picked up invulnerability to a particular ailment. The master energizes the body's safe system to see the administrator as a peril, wreck it, and keep a record of it, so the resistant structure would all be able to the all the more easily see and beat any of these littler scale life shapes that it later encounters. An immunization is the implantation of an executed or incapacitated animal that produces invulnerability in the body against that living thing. An immunization is the methodology by which a man or animal gets the opportunity to be protected from a disease Vaccines cause vaccination, and there are moreover a couple of infirmities that reason inoculation after an individual recovers from the ailment. Antibodies work genuinely well. Clearly, no pharmaceutical is perfect yet most puberty antibodies convey invulnerability around 90-100% of the time.

  • Intralymphatic Vaccination
  • CD4+ and CD8+ T Cell Responses
  • Monoclonal Antibodies
  • Vaccines for Routine and Selective uses
  • Routes of Vaccine Delivery

13.  Modern Technologies in Vaccine Discovery & Development

The exposure of vaccinations has incited to the nearby annihilation of a couple of basic contaminations and has enormously influenced prosperity for a reasonably insignificant exertion. Regardless, most antibodies being utilized today were created by frameworks that were led more than 100 years earlier and don't address the greatest limit of the field. The introduction of inherited building has fuelled quick advances in counter acting agent development and is as of now inciting to the section of new things in the business focus. Notwithstanding the way that these especially portrayed, sifted molecules are known guarded antigens, they have routinely been poor immunogens/inoculations, lacking safe power and immunogenicity since they never again have the physical outline of particles and in situ TLR agonists that different and perceive remote microorganisms for the protected structure.

  • Vaccine Research in Europe
  • Therapeutic Vaccination for Auto Immune Diseases
  • Vaccine Management & Quality Assurance
  • Vaccine Clinical Trials
  • Vaccine Discovery, Development and Formulation

14. Recombinant Vaccines

A recombinant immunization is an antibody delivered through recombinant DNA innovation. This includes embeddings the DNA encoding an antigen, (for example, a bacterial surface protein) that invigorates a resistant reaction into bacterial or mammalian cells, communicating the antigen in these cells and afterward sanitizing it from them.

  •         DNA vaccines
  •         Recombinant (protein subunit) vaccines

15. Poultry Vaccines

Inoculation has a vital influence in the wellbeing administration of the poultry rush. There are various sicknesses that are avoided by inoculating the flying creatures against them. An immunization keeps a specific illness by activating or boosting the winged animal's invulnerable framework to create antibodies that thusly battle the attacking causal creatures. A characteristic intrusion that really causes the ailment will have an indistinguishable outcome from the fowl will create antibodies that battles the present attack and also to forestall future attacks by the same causal life forms. Lamentably flying creatures that wind up infected generally progress toward becoming unthrifty, non-beneficial or even bite the dust. A contamination caused by characteristic attack will be uncontrolled and in this manner has the likelihood of causing serious harm; however immunization gives a method for controlling the outcome with insignificant damage to the flying creatures.

  •    E.coli Vaccines
  •    Pasteurella multocida vaccines
  •    Riemerella anatipestifer vaccines

16. Vaccines and Autism

Inoculations have gotten a lot of media and research consideration as a potential reason for extreme introvertedness. The logical research group has widely examined the provocative connection amongst extreme introvertedness and immunization. Various thorough examinations distributed in peer-checked on diaries have neglected to set up any relationship amongst a mental imbalance and measles, mumps, and rubella (MMR) inoculation. With his 1998 production in The Lancet, the British gastroenterologist Andrew Wakefield lighted a firestorm of debate when he suggested that the measles, mumps, and rubella (MMR) antibody causes autism.1 because of his claim, the MMR immunization and the immunization additive thimerosal are the most examined potential ecological reasons for a mental imbalance to date. Different investigations led by specialists in the United States, the United Kingdom, Europe, and Japan have neglected to set up any causative connection amongst immunizations and autism.2,3,4,5,6,7,8,9 Moreover, the impetus for the risky against antibody development, Wakefield's unique examination, has been formally withdrawn by The Lancet and denied by established researchers because of information falsification.10 Although the vaccine– extreme introvertedness interface has been generally ruined, the perilous misguided judgment that antibodies cause a mental imbalance perseveres even with no stable logical proof.

  •  Autistic Disorder
  •  Measles-mumps-rubella vaccine
  •  Thimerosal

17. Synthetic Vaccines

Engineered immunizations, specifically long manufactured peptides of roughly 25– 50 amino acids long, are appealing for HIV antibody advancement and for enlistment of remedial insusceptible reactions in patients with (pre-)dangerous disarranges. On account of preventive immunization improvement against HIV, no significant achievement has been accomplished, yet the conceivable outcomes are in no way, shape or form depleted. A long peptide antibody comprising of 13 covering peptides, which together cover the whole length of the two oncogenic proteins E6 and E7 of high-chance human papilloma infection write 16 (HPV16), caused finish relapse of all sores and annihilation of infection in 9 out of 20 ladies with high-review vulvar intraepithelial neoplasia, a treatment safe preneoplastic issue. The nature and quality of the antibody provoked T cell reactions were altogether connected with the clinical reaction. Manufactured peptide immunizations are alluring, in light of the fact that they permit reasonable change of antibody plan and nitty gritty pharmacokinetic and pharmacodynamic contemplates impractical with regular antibodies. Upgrades are conceivable by expansion or conjugation of adjuvants, eminently TLR ligands, to the manufactured peptides.

  • Neutralizing Antibody
  • T helper cell
  •  Peptide Vaccine

18. Hepatitis vaccines

Viral hepatitis is a genuine medical issue everywhere throughout the world. Notwithstanding, the decrease of the bleakness and mortality because of immunizations against hepatitis A and hepatitis B has been a noteworthy segment in the general lessening in antibody preventable infections. We will examine the study of disease transmission, immunization advancement, and post-inoculation impacts of the hepatitis A and B infection. Furthermore, we examine endeavours to give hepatitis D antibody to the 350 million people tainted with hepatitis B all around. Given the absence of a hepatitis C antibody, the numerous difficulties confronting the generation of a hepatitis C immunization will be appeared, alongside present and previous inoculation trials. As there is no present FDA-endorsed hepatitis E immunization, we will introduce inoculation information that is accessible in whatever is left of the world. At last, we will talk about the current difficulties and inquiries confronting future undertakings for every one of the hepatitis infections, with endeavours proceeding to centre on significantly diminishing the dismalness and mortality related with these genuine contaminations of the liver.

  •   Hepatitis A
  •   Hepatitis B
  •   Hepatitis C
  •   Hepatitis D

19. Travel and Edible Vaccines

Travel antibodies are prescribed to give security against ailments endemic to the nation of inception or of goal. They are proposed to ensure explorers and to avert infection spread inside and between nations. There is no single inoculation plan that fits all explorers. Each calendar must be individualized by the explorer's past inoculations, wellbeing status and hazard factors, the nations to be gone to, the sort and span of movement, and the measure of time accessible before flight. Eatable antibodies hold incredible guarantee as a financially savvy, simple to-direct, simple to-store, safeguard and sociocultural promptly adequate immunization conveyance framework, particularly for the poor creating nations. It includes presentation of chose wanted qualities into plants and after that actuating these changed plants to fabricate the encoded proteins.

  • Yellow Fever Vaccine
  • Travelers Diarrhoea
  • Routine Immunizations for travel

20. Human Vaccines

The principal course of rabies treatment was controlled under the supervision of Louis Pasteur, over a century back. From that point forward, rabies immunizations have dependably been among the first to profit by advance underway and control. As respects immunizations for human use, around 1955 there was a change from antibodies arranged from creature nerve tissue to embryonated eggs and soon a short time later, around 1960, to adjustment of rabies infection to societies of human diploid cells. The improvement of this antibody, which remains the reference immunization in relative investigations of immunogenicity, took long years. It was first enlisted in France in 1974 and somewhat later in North America. The late 1970s and the 1980s saw the advancement of a plenty of immunizations arranged on different cell substrates, for example, essential explant cells of hamster, canine or fetal calf kidney, fibroblasts of chicken developing life, or diploid cells from rhesus monkey fetal lung, lastly cells from nonstop lines (Vero cells). The creation of some of these immunizations was ceased toward the finish of the 1980s while others have been controlled to a huge number of patients.

  • Tuberculosis Vaccine
  • Bordetella Vaccine
  • OPV (Oral Poliovirus Vaccine)
  • Meningococcal /Menactra Vaccines
  • Smallpox Vaccine
  • Rotavirus Vaccine

21. Carbohydrate-based Vaccines

Starches are viewed as promising focuses for immunization improvement against irresistible ailment since cell surface glycan’s on numerous irresistible operators are credited to assuming a critical part in pathogenesis. Moreover, oncogenic change of ordinary cells, as a rule, is related with deviant glycosylation of the cell surface glycan creating tumor related sugar antigens (TACAs). Mechanical advances in glycobiology have added another measurement to immunotherapy while considering starches as key focuses in creating protected and powerful immunizations to battle disease, bacterial contaminations, viral diseases, and so on. Many consider compelling antibodies prompt T-cell subordinate invulnerability with acceptable levels of immunological memory that block repeat. Shockingly, sugars alone are inadequately immunogenic as they don't tie firmly to the MHC II complex and consequently neglect to evoke T-cell resistance.

  •  Abnormal carbohydrates expressed by tumors
  •  Choosing and designing proper adjuvants for specific targets
  •   Using adjuvants to improve immunogenicity and/or immunological properties of vaccines

22. Vaccines Experimentation

All immunization applicants must be put through a protracted, thorough procedure of logical assessment before they can be authorized for general utilize. This procedure is tedious – it can take up to 10 years just to move a hopeful immunization through the three periods of clinical advancement alone. Be that as it may, it is additionally imperative. The clinical trials in which antibodies are assessed guarantee that authorized immunizations are sheltered, powerful, and fitting for the populaces destined to utilize them. IAVI analysts have extensive involvement in connected research for antibody outline, the interpretation of immunization ideas into testable items, and the assessment of such immunization competitors in beginning period clinical trials.

  •  Basic Research
  •  Discovery 
  •  Preclinical Evaluation
  •  Manufacturing and Regulatory Review
  •  Clinical Evaluation

23. Vaccines for pregnant women and neonates

Immunizations can help keep you and your developing family solid. On the off chance that you are pregnant or arranging a pregnancy, the particular immunizations you require are controlled by elements, for example, your age, way of life, restorative conditions you may have, for example, asthma or diabetes, sort and areas of travel, and past inoculations. The Advisory Committee on Immunization Practices (ACIP) suggests that all youngsters get their first dosage of Hepatitis B antibody during childbirth and finish the antibody arrangement by age 6– year and a half.

  •   Immunization during or before pregnancy / delivery
  •   HIV and other STD vaccines for pregnant women
  •   Influenza vaccination of pregnant women and protection of their infants
  •   HPB, HAV, HBV vaccination for neonates
  •   Whooping cough vaccines in pregnant women
  •    Halting vaccination in pregnancy
  •    Chiropractic vaccination care in women and pregnancy

24. Vaccine Delivery systems and Adjuvants

Routinely the proficiency of an adjuvant is measured by the ability to instigate upgraded Vaccine serum titers and cell interceded invulnerability (CMI) to a given antigen. In the early period of inoculation a few adjuvants impact the antigen organization and take-up by a purported terminal impact exemplified by aluminium hydroxide gel and oil adjuvants, which conceivably isn't as wanted as alleged.

  • Inulin-derived adjuvant
  • Cytokines as adjuvants·       
  • Bacteria-derived adjuvants
  • Tensioactive adjuvants
  • Organic & inorganic adjuvants
  • Aluminum in vaccines
  • Latest techniques and advancements in vaccines delivery systems

25. Novel Vaccines Production and Development

Roughly 250 researchers and immunization specialists from around the globe assembled at Cambridge Healthtech Institute's third Annual Immunotherapeutic and Vaccine Summit (ImVacS 2008) to show the most recent advancements in this field and to talk about, in 64 introductions, the difficulties and flow ways to deal with improvement and generation of novel antibodies.

  • Production using plant, insect cells or bacteria cultures
  • Clinical development of vaccines
  • Investigational vaccines manufacture
  • Mammalian cells-based vaccines
  • Egg-based vaccines

26. Plant-based Vaccines

The vaccines in which the desired genes that encode the antigen protein for specific disease are introduced into the genome of plant tissue by various methods are termed as plant-based vaccines. The most common procedures that are used to yield effective plant-based vaccines are Agrobacterium-mediated gene transfer and Transformation via genetically modified plant virus. Though, growth in the field of science and technology established new approaches such as agro infiltration, biolistic, electroporation, polyethylene glycol treatment and sonication to replace the former methods.

  • To increase the efficacy of gene delivery
  • Plastid Methods transformation
  • Immunogen design and gene synthesis
  • Plant based vaccines production
  • Challenges of plant based vaccines

27. Biotechnology and Modern Vaccine Technology

Biotechnology is used in the evolution of vaccine in three different processes: Using a special monoclonal antibody in the segregation of pure antigens, using cloned genes for the synthesis of antigens, synthesized proteins used as vaccinesRecombinant vaccines are vaccines yielded from recombinant DNA Technology. They are also termed as subunit vaccines.

  • Recombinant vaccines
  • Hydrophobic Nanoparticle Technology
  • TLR Agonists
  • Surfaced Arrayed Therapeutics
  • Immunopurification
  • Synthetic peptides
  • Modern vaccine formulation technologies

28. Biodefense Vaccines against Bioterrorism

In spite of the defensive adequacy of antibodies against singular living beings, the high expenses and the considerable troubles associated with inoculating extensive populaces, alongside the expansive range of potential operators, make it difficult to utilize immunizations to secure the all-inclusive community against bioterrorism.

  • Anthrax and  smallpox
  • Plague and tularemia
  • Ebola, Marburg, Lassa, and machupo virus
  • Q fever, ricin toxin, typhus fever
  • Nipah virus

29. Vaccines against Drugs

Globally, drug addiction is a severe problem. One therapy being considered is vaccines against drugs of abuse. The antibodies obtained against the drug can take up the drug and avert it from reaching the reward center in the brain. Few such vaccines have entered clinical trials, but research is going on rapidly.

  • Nicotine vaccines
  • Morphine and heroin vaccines
  • Drug molecules and immune system
  • Linkage chemistry, adjuvants and immunological proteins
  • Cocaine vaccines

30. Preventable Disease Vaccines

An antibody preventable sickness is an irresistible malady for which a compelling preventive immunization exists. On the off chance that a man procures an immunization preventable ailment and passes on from it, the demise is viewed as an antibody preventable passing.

  • Diphtheria
  • Haemophilus influenzae serotype b disease
  • Hepatitis B
  • Meningitis
  • Tuberculosis
  • Yellow fever
  • Mumps
  • Measles

31. Entrepreneurs Investment Meet

Enterprise is the way toward outlining, propelling and maintaining another business, which is regularly at first a private venture. The general population who make these organizations are called business people.

Enterprise has been portrayed as the "limit and ability to create, arrange and deal with a business wander alongside any of its dangers keeping in mind the end goal to make a profit”. While meanings of enterprise normally center around the starting and running of organizations, because of the high dangers associated with propelling a start-up, a huge extent of new companies need to close because of "absence of financing, awful business choices, a monetary emergency, absence of market request—or a blend of these.

  •    Developing a business plan
  •    Hiring the human resources
  •    Acquiring financial and material resources
  •    Providing leadership
  •    Being responsible for both the venture's success or failure
  •    Risk Aversion

32.  Polio Vaccines

Inoculation can shield individuals from polio. Polio is an ailment caused by an infection. It is spread primarily by individual-to-individual contact. It can likewise be spread by expending nourishment or beverages that are tainted with the excrement of a contaminated individual.

A great many people contaminated with polio have no indications, and numerous recoup without inconveniences. Be that as it may, here and there individuals who get polio create a loss of motion (can't move their arms or legs). Polio can bring about changeless inability. Polio can likewise cause passing, for the most part by incapacitating the muscles utilized for relaxing.

  •          Inactivated Polio Vaccine (poliomyelitis)
  •          Trivalent oral polio vaccine
  •          Bivalent oral polio vaccine
  •          Monovalent oral polio vaccines

33. Vaccines Business and Development:

Comprise a number of tasks and processes generally aiming at developing and implementing growth opportunities within and between organizations. It is a subset of the fields of business, commerce, and organizational theory. Vaccine development programs face several challenges that set them apart from other types of healthcare product development programs.

  •          Vaccine supply chain logistics
  •          Vaccines Export and Import
  •          Vaccine Business

34. Pet Nutrition role in Vaccination:

From the simple first day you bring another pet home through the last long periods of its life, sustenance assumes a basic part in your pet's general wellbeing and prosperity. Numerous pet proprietors underestimate nourishment, to a limited extent in light of the fact that the accessibility of such a significant number of nutritiously entire business weight control plans has removed a great part of the mystery from picking an appropriate eating regimen for a pet. Notwithstanding, did you realize that your pet's nourishing needs change with age and movement level? Did you realize that uniquely figured weight control plans can aid the administration of different restorative conditions, including kidney ailment, diabetes, joint pain, and coronary illness? Do you know what number of calories your pet ought to have every day and whether you are finished or starving? Is it accurate to say that you are open to perusing and translating pet sustenance marks?

  •          Pet Vaccination
  •          Pet Nutrition

35. Influenza Vaccination:

Flu is a genuine ailment that can prompt hospitalization and in some cases even passing. Each influenza season is extraordinary, and flu disease can influence individuals in an unexpected way, yet a large number of individuals get this season's flu virus consistently, a huge number of individuals are hospitalized and thousands or countless individuals kick the bucket from influenza-related causes each year. Indeed, even solid individuals can become ill from this season's cold virus and spread it to others. CDC assesses that influenza-related hospitalizations since 2010 went from 140,000 to 710,000, while influenza-related passings are evaluated to have extended from 12,000 to 56,000. Amid influenza season, influenza infections flow at more elevated amounts in the U.S. populace. ("Influenza season" in the United States can start as ahead of schedule as October and last as late as May.) A yearly regular influenza antibody is the most ideal approach to lessen your danger of becoming ill with occasional influenza and spreading it to others. At the point when more individuals get inoculated against this season's cold virus, less influenza can spread through that network.

  •          Live Attenuated Influenza Vaccine
  •          Quadrivalent Influenza Vaccine
  •          Flublok seasonal Influenza Vaccine

Market Report

Euro Vaccines 2018 welcomes attendees, presenters, and exhibitors from all over the world to Budapest, Hungary. We are delighted to invite you all to attend and register for the “European Congress on Vaccines & Vaccination” which is going to be held during October 26-27, 2018 at Budapest, Hungary

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Euro Vaccine 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Vaccines organizing committee look forward to meeting you in Budapest.

Importance & Scope:

Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) and Type - Forecast to 2022", The antibodies showcase is relied upon to achieve USD 49.27 Billion by 2022 from USD 34.30 Billion of every 2017, at a CAGR of 7.5%. The development of the market is ascribed to the rising predominance of illnesses, expanding government and nongovernment subsidizing for antibody improvement, and expanding ventures by organizations.

In view of innovation, the Vaccines showcase is divided into conjugate antibodies, inactivated and subunit Vaccines, live lessened antibodies, recombinant antibodies, and toxoid antibodies. In 2017, the conjugate section is relied upon to represent the biggest offer of the antibodies advertise. The development in this market is for the most part determined by expanding speculations by the legislature of creating countries and rising pervasiveness of irresistible maladies.

In 2017, North America is required to rule the market. The huge offer of this topographical portion is ascribed to elements, for example, expanding ventures by government associations and organizations to advance inoculation and additionally grow new Vaccines. In 2017, Europe is relied upon to hold the second biggest offer of this market. Factors, for example, accessibility of subsidizing and funding ventures for the advancement of new antibodies and expanding government activities are required to drive advertise development in this locale.

The investigation appraises the antibodies advertise estimate for 2017 and ventures its request till 2022. In the essential research process, different sources from both request side and supply side were met to acquire subjective and quantitative data for the report. Essential sources from the request side incorporate different industry CEOs, VPs, showcasing chiefs, innovation and development executives, and related key officials from the different players in the Vaccine advertise. For the market estimation process, both best down and base up approaches were utilized to gauge and approve the market size of the worldwide market and in addition to assess the market size of different other ward submarkets. Every single conceivable parameter that influence the market shrouded in this examination contemplate have been represented, seen in broad detail, confirmed through essential research, and broke down to get the last quantitative and subjective information. This information was combined and added to itemized sources of info and investigation.

Euro Vaccine 2018 is an international platform for presenting research about Novel Vaccines - Research and Development, Cancer Vaccines, Vaccines Formulation & Discovery, DNA Vaccines, Novel Vaccines - Development and Production, Vaccine Delivery Systems and Adjuvants, Hepatitis, HIV and STD Vaccines, Vaccination for Emerging and Re-emerging Diseases, Biodefense Vaccine against Bioterrorism, Vaccines for Immune Mediated Diseases, Vaccines for Pregnant Women and Neonates, Antibodies : Engineering and Therapeutics, Animal Models and Clinical Trials, Future Challenges & Current Research and Others for the benefit of both the academia and business. This event brings together world class scientists, Researchers and Academicians to explore the recent advancements that are taking place in the field of Vaccines & Vaccination.


Why Budapest?

Rated one of Europe's top destinations, a visit to Budapest means a schedule packed full of museums, attractions, nightlife and more. Here you will find plenty of information to offer your clients a unique and memorable visit to Budapest.

Visitors of all types will have plenty to do while they’re here. The city’s cultural agenda is packed with world-class exhibitions, theatre performances, live music and other unique events, and its charming neighbourhoods are full of unique shops, cafes and restaurants. The resources below will help you navigate these, and plan the right itinerary for your guests.

Most parents in Hungary(over 95%) have their children vaccinated. The first round is performed between the ages of 0 and 4. When they reach the age of 9, two vaccinations are repeated: DTP (diphtheria, tetanus and polio) and MMR (measles, mumps and rubella; in Dutch BMR). Girls are also offered vaccination to protect them against cervical cancer in the year they turn 13. These vaccinations are free of charge.

Conference Highlights:

  • HIV/AIDS Vaccines
  • Vaccines safety and Efficacy
  • Vaccines Research and Development
  • Mucosal Vaccines
  • Fish Vaccines
  • Production and research of Vaccines
  • Vaccines for Pregnant women and neonates
  • Vaccines and Immunization
  • Modern technologies in Vaccine discovery and Development
  • Recombinant Vaccines
  • Poultry Vaccines
  • Synthetic Vaccines
  • Hepatitis Vaccines
  • Travel and Edible Vaccines

Learn More

Recommended EuroSciCon conferences:

CNS 2018, Oct 22-23, 2018 Greece | Oncology 2018, Nov 05-06 , 2018 France | Liver & Pancreatic Diseases, Nov 12-13, 2018 France | Hepatology & Hepatitis , Nov 12-13, 2018 France | Orthopedics, Nov 29-30, 2018 Netherlands | Nursing & Healthcare, Dec 3-4, 2018 Netherlands | Dementia, Dec 6-7, 2018 Netherlands | Chemistry Research, Dec 10-11, 2018 Netherlands | Clinical pathology , Feb 27-28, 2019 Czech Republic | Euro Gastro 2019, March 11-12, 2019 Netherlands| Dental & Dental Hygiene, March 25-26, 2019 Hungary | Data Analytics , April 08-09, 2019 France | Dermatology 2018, April 18-19, 2019 France | Microbiology and Virology, April 22-23, 2019 Greece | Infectious Diseases & Std-Aids 2019 April 15-16, 2019 France | Quantum & Plasma physics , May 09-10, 2019 Sweden | Euro Optics , May 09-11, 2019 Sweden | Advance Nursing Practice, May 23-24, 2019 Sweden | Psychiatry & Psychology , April 11-12, 2019 France | Renewable and Green Energy, March 21-22, 2019 Netherlands| Nano 2019, Oct 07-09, 2019, Japan | Advanced Energy Materials, Oct 07-09, 2019 Japan | Materials Science & Engineering, June 04-06, 2019 France | Nursing Diagnosis, July 25-26, 2019 Luxembourg |Nursing & Midwifery, May 23-24, 2019  Sweden | Nuclear Medicine & Radiation Therapy, June 10-12, 2019 Netherlands


Immunology and Vaccine Universities in Europe

Ludwig Maximilians University Munich, Germany | Charité-Universitätsmedizin Berlin, Germany | Wroclaw Medical University, Wroclaw, Poland | Finnish Institute of Occupational Health, Helsinki, Finland | Technical University Munich, Germany | University of Pisa, Italy | University of Messina, Messina, Italy University Laboratory of Medical Research-University of Verona, Italy | Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark | Wageningen University, the Netherlands | University Medical Centre Utrecht, The Netherlands | National Institute of Allergy and Infectious Disease | University of Bologna, Bologna, Italy  | Clermont-Ferrand, France | Imperial College London, London | Manchester Institute of Biotechnology | University Hospitals of Geneva and University of Geneva, Geneva, Switzerland | Centre for HIV Research | Zealand University Hospital, Denmark | Odense University Hospital, Denmark | Aarhus University, Denmark | Tampere University Hospital, Tampere, Finland | University of Tampere School of Medicine and Fimlab Laboratories, Tampere, Finland | Helsinki University Central Hospital, Helsinki, Finland | University of Foggia, Italy | National Research Council (CNR), Avellino, Italy | University of TampereOslo University Hospital, Norway | Norwegian Institute of Public Health, Oslo, Norwa | University of Bonn, Bonn, Germany | University of Warmia and Mazury, Olsztyn, Poland Montana State University, Bozeman, Montana | Medical University of Vienna, Vienna, Austria Second University of Naples, Naples, Italy | University of Copenhagen, Hellerup, Denmark |  Necker Children's Hospital, Paris, France | Paracelsus Private Medical University Salzburg, Austria Medical University of Innsbruck, Austria | Krankenanstalt Rudolfstiftung, Wien, Austria | Bispebjerg University Hospital, Copenhagen, Denmark | University of Lille, France | 

Immunology and Vaccine Universities in USA

University of British Columbia, Vancouver, Canada | McGill University Faculty of Medicine,Montreal, Canada | University of Manitoba, Winnipeg, MB, Canada | University of Saskatchewan, Saskatoon, SK, Canada | Vaccine Researcg Center Labs | University of Veracruz, Veracruz, México | Stanford University, Stanford, USA | Universidad Autonoma de Sinaloa, Mexico | University of California, Davis, USA | Federal University of Bahia, Salvador, Bahia, Brazil | Universidad Autónoma, Mexico | University of Sao Paulo School, Brazil | University Estadual Paulista, Brazil | College of Medicine Miguel Aleman Valdes, Veracruz, Veracruz, Mexico | Vaccine and Infectious Disease DivisionUniversity of Brasília, Brasília, Brazil | Institute of Biomedical Research, Brazil | Centre for Vaccine Awareness and ResearchDepartment of Internal Los Alamos National Laboratory, Los Alamos, New Mexico, USA |McMaster University, Hamilton, Ontario, Canada | Health Sciences Centre, Winnipeg, MB, Canada | Western University, London | McGill University and Research Institute, Canada | Royal University Hospital, CanadaMedicine, University of New Mexico, USA | Vaccine Research Unit | Dalhousie University, Halifax, Nova Scotia, Canada | University of Alberta, Edmonton, Canada | University of Toronto, Toronto, Canada | Memorial University of Newfoundland, Canada | University Avenue, Toronto, Ontario, Canada | University of New Mexico Cancer Center, Maxico  | Universidad Autónoma de Nuevo León, Monterrey, Mexico | Duke Human Vaccine InstituteZealand's University Hospital, Koge, Denmark | Hospital Infantil de México Federico Gómez, México | Biomedicine In the Post-Genomic Era, Mexico | Nuevo Hospital Civil de Guadalajara, Mexico | Centro de Ciencias de la Atmósfera, Mexico | Université de Montréal, Montreal, Quebec, Canada | 

Immunology and Vaccine Universities in Asia

The University of Western Australia, Perth, Australia | The Chinese University of Hong Kong | Prince of Wales Hospital, Hong Kong, China | Singapore Clinical Research InstituteThe Hong Kong Polytechnic University, Hong Kong, China |  Nanchang University, Nanchang, China |  The University of Hong Kong, Hong Kong, China | 7 Baptist University Road, Kowloon Tong, Hong Kong, China | Gadjah Mada University, Yogyakarta, Indonesia | International Vaccine InstituteTrivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India | University of Putra Malaysia | Andalas University-M. Djamil Hospital, Padang, Indonesia | Bina Nusantara University, Jakarta, Indonesia | University of Indonesia, Jakarta, Indonesia |  Seirei Hamamatsu Hamamatsu, Shizuoka, Japan | Wakayama Medical University, Kimiidera, Japan | UCSI University, Malaysia | Institute for Medical Research, Kuala Lumpur, Malaysia | Asia Research InstituteUniversity of Otago, Christchurch, Christchurch, New Zealand | Murdoch Childrens Research Institute, Melbourne, Australia | University of Sydney, Sydney, New South Wales, Australia | The University of Melbourne | University of Newcastle, Tamworth, Australia | The University of Auckland, New Zealand | The Medical City Hospital, Pasig City, Philippines | National University of Singapore, Singapore | Kyungpook National University, Daegu, South Korea | United Arab Emirates University, UAE | National Taiwan University Hospital, Taipei, Taiwan | International Livestock Research Institute | Zhejiang University School of Medicine, Hangzhou, China Hong Kong Polytechnic University, Hong Kong, China | Yamaguchi University Graduate School of Medicine, Ube, Japan | Central Health Medical Practice, Hong Kong, China |

Top Immunology Societies and Associations Worldwide

Council on Foreign Regulations | NCD Alliance | Global Health Council |Non Communicable Diseases | General Assembly of the United Nations | Pan American Group for Immunodeficiency | Society for Immunotherapy of Cancer Dutch Society of Allergology | Norwegian Society of Allergology and Immunopathology | Polish Society of Allergology | International Society of VaccinesInternational Federation of Red Cross and Red Crescent Societies( IFRC) | International Society for Disease Surveillance | World Health Federation | Australasian Society of Clinical Immunology and Allergy | National Institute of Immunology | British Society for Immunology  | International Society for Vaccines  | International Society of Neuroimmunology  | The Japanese Society for Neuroimmunology | Latvian Society of Neuroimmuologists | Non Communicable Diseases- World Medical Association | World Health Organization| Non Communicable Diseases | Immunization Action Coalition | Global Health and Non communicable Diseases  |  European Federation of Immunological Societies: EFIS | European Academy of allergy and clinical immunology Immunological Association in UK | The American Association of Immunologists (AAI)|  American Academy of Allergy, Asthma & Immunology | Federation of Clinical Immunology Societies (FOCIS) | American Association of Veterinary Immunologists (AAVI) | Nature Immunology Association American Society for Reproductive Immunology | Allergy/Immunology American Medical Association | American Association of Immunologists Association of Medical Laboratory Immunologists | Immunology of Diabetes Society | International Cytokine Society International Society for Neuroimmunology | International Society of Developmental and Comparative Immunology | International Union of Immunological Societies | Pan American Group for Immunodeficiencies| Society for Mucosal Immunology | European academy of Tumor Immunology |  Cyprus Society for Allergology and Immunology | Czech Society of Allergology and Clinical Immunology | Danish Society of Allergology | Estonian Society for Immunology and Allergology | Finnish Society of Allergology and Immunology |  Hungarian Society of Allergology and Clinical Immunology | Icelandic Society of Allergology and Clinical Immunology | Irish Association of Allergy and Immunology | Italian Society of Allergology and Clinical Immunology | Latvian Association of Allergist | Lithuanian Society of Allergology and Clinical Immunology | SocieteLuxembourgeoised’Allergologie et d’Immunologie F.Y.R.O.M. Society of Allergy and Clinical Immunology |American Society for Histocompatibility and Immunogenetics | Asia Pacific Associationof Pediatric Allergy, Respirology& Immunology (APAPARI) | Asia-Pacific Histocompatibility and Immunogenetics Association (APHIA) | International Union of Immunological Societies | Pediatric Allergy and Immunology and Association | Allergy & Immunology Society of Sri Lanka | Allergy and ClinicalImmunology Society (Singapore) | American Academy of Allergy, Asthma and Immunology | British Society for Immunology | Commonwealth of Independent States Society of Allergology and Clinical Immunology | Clinical Immunology Society |  Portuguese Society of Allergology and Clinical Immunology | Romanian Society of Allergology and Clinical Immunology | Russian Association of Allergology and Clinical Immunology | Association for Allergology and Clinical Immunology of Serbia| Slovakian Society of Allergology and Clinical Immunology | Slovene Association of Allergology and Immunology | Spanish Society of Allergology and Clinical Immunology | Swedish Association for Allergology | Swiss Society of Allergology and Immunology | Turkish Society of Allergy and Clinical Immunology | Ukrainian Society of Allergy and Clinical Immunology | Georgian Association of Allergology and Clinical Immunology German Society for Allergology and Clinical Immunology | Hellenic Society of Allergology and Clinical Immunology | Australasian Society for Immunology | Federation of Immunological Societies of Asia-Oceania |  Belgian Society for Allergy and Clinical Immunology | British Society for Allergy and Clinical Immunology | Clinical Centre of Allergology | Croatian Society for Allergology and Clinical Immunology |

Top Immunology and Vaccine Journals Worldwide

Journal of Allergy and Clinical Immunology | Journal of Clinical Immunology | Molecular Immunology | Human Vccines & Immunotherapeutics | Microbiology | Vaccine | European Journal of Immunology | Nature | Pediatric Allergy and Immunology | Clinical and Experimental Immunology | Clinical and Vaccine Immunology | Elsevier Journal of VaccineNature Reviews Immunology | Immunology and Cell Biology | Nature Immunology | International Immunology | International Journal of Vaccines and ImmunizationAnnals of Allergy, Asthma & Immunology | Immuno biology | Cell | Human Immunology | Veterinary Immunology and ImmunopathologyInfection and Immunity | Allergy | Immuno pharmacology | American Journal of Reproductive Immunology | Journal of Neuroimmunology | World journal of VaccineCancer Immunology, Immunotherapy | Journal of Asthma | Brain, Behavior, and Immunity | Critical Reviews in Immunology | Clinical Reviews in Allergy & Immunology | Cytokine | Immunity| Medical Microbiology and Immunology | NPJ Vaccines JournalInternational Reviews of Immunology | Immuno genetics | Clinical & Experimental Allergy | Immunotherapy journal | Inflammation Research | Autoimmunity | Journal of Leukocyte Biology | Journal of Leukocyte Biology Wiley | Journal of Investigational Allergology and Clinical Immunology | Clinical and Experimental Vaccine ResearchInternational journal of immunotherapy | journal of immunotherapy of cancer | Veterinary immunology journal | European journal of allergy and clinical immunology | American Journal of Immunology | Journal of Clinical Immunology | Journal of Immunology Research | American Journal of clinical and experimental Immunology | Journal of clinical Immunology |  Asian Pacific Journal of Allergy and Immunology NCBI | European Journal of Experimental Biology | Journal of Vaccines & Vaccination | Rheumatology: Current ResearchJournal of Blood & Lymph | Immunome Research | Journal of Immunological Techniques & Infectious Diseases | Immunogenetics: Open Access | Journal of Autoimmune Disorders | Journal of Vasculitis | Immunochemistry & Immunopathology | International Journal of Inflammation, Cancer and Integrative Therapy | Journal of Cancer Research and Immuno-Oncology | Journal of Clinical and Experimental Transplantation | Journal of Transmitted Diseases and ImmunityImmunological Disorders & Immunotherapy | Archives of Inflammation | Journal of Vaccines & Clinical Trials

Immunology and Vaccine Job Opportunities

Scientific Research in Immunology | Physicians and Pediatricians in Immunology | College Teaching and Research of Immunology | In Vivo Research Scientist in VaccineAssociate Professor of  Immunology | Assistant Professor of  Immunology | 2018 MRL Immunology Intern Auto-Antigens in Autoimmune Diseases | Cancer Immunologist & System biologist | Directors of Research Divisions and SWIMSPost-doctoral positions in Immunotherapy | Associate Scientist in ImmunochemistryResearch Faculty in Immunology | Postdoctoral Researcher in Tumor Immunology | Postdoctoral Fellow - Diabetes, Obesity & Metabolism Institute | Senior Translational Scientist in Immunology | Postdoctoral Fellow  in Immunology | Associate Editorial in Immunology |  Project Manager in Immunology | Principal Investigator | Post Doctoral Position in Huntington's Disease Research in ImmunologyBiomedical Sciences Faculty Positions - Cluster Hire in Immunology | Assistant Professor of Immunology at MIT-Ragon Institute | Computational Biology Faculty Position in Immunology | Principal Investigator - Infectious Disease Research | Associate Program Officer, Crohn's Disease in Immunology | Assistant or Associate Professor - Immunologist/Immunopathologist  | Faculty Position in Biomedical Engineering at UC Davis in Immunology | Research Scientist Position: Cellular Immunotherapy (GMP) R&D Lead | Chif Scientific Officer and Vice President, Science and Education in Immunology | Senior Scientific Writer in Immunology Pathology FTE Immunogenetics in Immunology  | Immune Assessment in Immunology | Assistant Professor of Human Disease Models in Immunology | Post-doctoral Position in Mucosal Immunology/Inflammatory Bowel Disease | Senior Faculty Positions in the Life Sciences Translational Research in Gastrointestinal & Hepatobiliary Cancers | Cancer Experimental Therapeutics | Research Associate Technician-Therapeutic Tumor  | Assistant Professor, Marine Disease Biology | Principal Investigator of Immunology | Post Doc in Immunology & Respiratory Diseases Research in Immunology  | Post-Doctoral Scientist position in Immunology Tenure Track Assistant Professor in Immunology | Postdoctoral Research Fellow in Immunology | Faculty Position in Immunology

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!